
3.83BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US87583X1090
CUSIP
87583X109
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
6.09
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.85
Wall Street Target Price
47.09
EPS Estimate Current Year
-1.40
EPS Estimate Next Year
-1.69
EPS Estimate Current Quarter
-0.3239
EPS Estimate Next Quarter
-0.3303
Most Recent Quarter
-
Revenue TTM
53,811,000
Gross Profit TTM
-79,839,000
EBITDA
-134,424,992
Profit Margin
-229.92%
Return On Assets TTM
-12.99%
Return On Equity TTM
-21.34%
Revenue Per Share TTM
0.398
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-0.85
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
71.1904
Price Book MRQ
3.7375
Enterprise Value Revenue
52
Enterprise Value EBITDA
0
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%